Sign up to save your podcasts
Or
Share EY-103 a novel Wnt Pathway Agonist for Treatment of DME and neovascular AMD
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
EY-103 a novel Wnt Pathway Agonist for Treatment of DME and neovascular AMD
We discuss remarkable preliminary results from the the use of intravitreal EYE-103, a novel Wnt pathway agonist in the treatment of DME and neovascular AMD with Dr. Charles Wykoff of Houston Texas.
View all episodes
By Retina Synthesis
4.5
88 ratings
We discuss remarkable preliminary results from the the use of intravitreal EYE-103, a novel Wnt pathway agonist in the treatment of DME and neovascular AMD with Dr. Charles Wykoff of Houston Texas.
More shows like Retina Synthesis
View all
Ophthalmology off the Grid by Eyetube
43 Listeners
New Retina Radio by Eyetube
18 Listeners
Straight From The Cutter's Mouth: A Retina Podcast
97 Listeners
JAMA Ophthalmology Author Interviews
5 Listeners
The Journal.
6,062 Listeners
MedEdTalks - Ophthalmology
4 Listeners
Headlight in the fog: The Uveitis Podcast
21 Listeners
Pupil Pod
10 Listeners
Experts InSight
50 Listeners
RETINA Journal Podcasts
11 Listeners
Ophthalmology Journal
19 Listeners
ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum
0 Listeners
Talking Euretina
1 Listeners
Mayo Clinic Ophthalmology Podcast
18 Listeners
ASRS's History of Retina
0 Listeners